Back to search

Virginia Commonwealth University

Novel Analogs of m-Chlorophenylguanidine as 5-HT3 Receptor Ligands

Abstract

dc:description.abstract

Serotonin receptors play a variety of functional roles in the body. Some indications and treatment claims for one of the classes of serotonin receptors, the 5-HT3 receptor family, include: anxiety, depression, chemotherapy- and radiation-induced emesis, constipation, irritable bowel syndrome, pain, drug addiction, and satiety control. A 5-HT3 receptor partial agonist, MD-354, served as a lead compound in the development of new 5-HT3 receptor ligands. Using halogenated analogs the study investigated their effect on binding to the 5-HT3 receptor. Conformationally-constrained analogs (quinazolines) were shown to be a novel class of 5-HT3 receptor antagonists. The log P values were determined for several analogs, and indicated that these ligands should be able to penetrate the blood-brain barrier. A homology model of the 5-HT3 receptor was built and the docking modes were assessed for these two series. Quinazolines were investigated for antidepressant properties using the mouse tail suspension test, and were shown to possess antidepressant-like activity.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Medicinal Chemistry

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Alix, Katie
Contributors dc:contributor
  • Malgorzata Dukat
  • Richard Glennon
  • Richard Young
  • Aron Lichtman

Subjects

dc:subject × 10

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Alix, Katie. Novel Analogs of m-Chlorophenylguanidine as 5-HT3 Receptor Ligands. Thesis thesis, https://doi.org/10.25772/60FB-7F94